hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_12923.1
Complex Portal: CPX-13422
Confidence: Medium  
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| EP300 | Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) | 5 | UniProt   NCBI |
| RBL2 | Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) | 5 | UniProt   NCBI |
| MATCAP1 | Microtubule-associated tyrosine carboxypeptidase 1 (EC 3.4.17.17) (Microtubule-associated tyrosine carboxypeptidase) | 5 | UniProt   NCBI |
| BDH2 | Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1) | 5 | UniProt   NCBI |
| CITED2 | Cbp/p300-interacting transactivator 2 (MSG-related protein 1) (MRG-1) (P35srj) | 5 | UniProt   NCBI |
| RBL1 | Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1) | 5 | UniProt   NCBI |
| C3orf62 | Uncharacterized protein C3orf62 | 3 | UniProt   NCBI |
| CREBBP | CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-) | 5 | UniProt   NCBI |
| CITED1 | Cbp/p300-interacting transactivator 1 (Melanocyte-specific protein 1) | 5 | UniProt   NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
|   REAC:R-HSA-8866907 | 3.29426179613e-09 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | Activation of the TFAP2 (AP-2) family of transcription factors |
|   WP:WP366 | 3.68386095669e-07 | 0.555555555556 | CITED1 CREBBP RBL1 EP300 RBL2 | TGF beta signaling pathway |
|   REAC:R-HSA-8864260 | 6.37877602254e-07 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors |
|   REAC:R-HSA-1234158 | 1.33765378004e-06 | 0.333333333333 | CITED2 EP300 CREBBP | Regulation of gene expression by Hypoxia-inducible Factor |
|   REAC:R-HSA-9614085 | 7.54535758839e-06 | 0.444444444444 | CITED2 CREBBP EP300 RBL2 | FOXO-mediated transcription |
|   REAC:R-HSA-9614657 | 2.1343196228e-05 | 0.333333333333 | CITED2 EP300 CREBBP | FOXO-mediated transcription of cell death genes |
|   REAC:R-HSA-6804114 | 2.59087532521e-05 | 0.333333333333 | RBL1 EP300 RBL2 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest |
|   GO:1903846 | 3.50368755955e-05 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | positive regulation of cellular response to transforming growth factor beta stimulus |
|   GO:0030511 | 3.50368755955e-05 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | positive regulation of transforming growth factor beta receptor signaling pathway |
|   KEGG:04110 | 6.70046738012e-05 | 0.444444444444 | CREBBP RBL1 EP300 RBL2 | Cell cycle |
|   CORUM:4 | 8.20609246787e-05 | 0.222222222222 | EP300 CREBBP | Multisubunit ACTR coactivator complex |
|   CORUM:571 | 8.20609246787e-05 | 0.222222222222 | EP300 CREBBP | p300-CBP-p270 complex |
|   HP:0011682 | 0.00014155117386 | 0.333333333333 | CITED2 EP300 CREBBP | Perimembranous ventricular septal defect |
|   KEGG:05203 | 0.000153939225096 | 0.444444444444 | CREBBP RBL1 EP300 RBL2 | Viral carcinogenesis |
|   CORUM:1471 | 0.000273361732609 | 0.222222222222 | EP300 RBL2 | pRb2/p130-multimolecular complex (RB2, E2F5, HDAC1, SUV39H1, P300) |
|   CORUM:2638 | 0.000273361732609 | 0.222222222222 | EP300 CREBBP | HES1 promoter corepressor complex |
|   HP:0034227 | 0.000306458653145 | 0.222222222222 | EP300 CREBBP | Aortic isthmus hypoplasia |
|   HP:0001042 | 0.000306458653145 | 0.222222222222 | EP300 CREBBP | High axial triradius |
|   HP:0005895 | 0.000306458653145 | 0.222222222222 | EP300 CREBBP | Radial deviation of thumb terminal phalanx |
|   HP:0008107 | 0.000306458653145 | 0.222222222222 | EP300 CREBBP | Plantar crease between first and second toes |
|   CORUM:6444 | 0.000409911647195 | 0.222222222222 | RBL2 RBL1 | SMAR1-HDAC1-SIN3A-SIN3B-p107-p130 repressor complex |
|   CORUM:5118 | 0.000409911647195 | 0.222222222222 | EP300 RBL2 | RBL2 complex (E2F4, E2F5, HDAC1, SUV39H1, P300, RBL2) |
|   REAC:R-HSA-6791312 | 0.000536007609173 | 0.333333333333 | RBL1 EP300 RBL2 | TP53 Regulates Transcription of Cell Cycle Genes |
|   CORUM:570 | 0.000573693030134 | 0.222222222222 | EP300 CREBBP | p300-CBP-p270-SWI/SNF complex |
|   REAC:R-HSA-3134973 | 0.000798060792831 | 0.222222222222 | EP300 CREBBP | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production |
|   KEGG:04350 | 0.000843198484996 | 0.333333333333 | CREBBP EP300 RBL1 | TGF-beta signaling pathway |
|   HP:5200232 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Phobia |
|   HP:0000756 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Agoraphobia |
|   HP:0005363 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Humoral immunodeficiency |
|   HP:0006200 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Widened distal phalanges |
|   HP:0008752 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Laryngeal cartilage malformation |
|   HP:0005322 | 0.000919082356402 | 0.222222222222 | EP300 CREBBP | Prominent nasal septum |
|   KEGG:05165 | 0.000943854596602 | 0.444444444444 | CREBBP RBL1 EP300 RBL2 | Human papillomavirus infection |
|   GO:0003682 | 0.000964358726778 | 0.666666666667 | RBL2 RBL1 CITED2 EP300 CITED1 CREBBP | chromatin binding |
|   HPA:0301361 | 0.000973189100113 | 0.666666666667 | BDH2 RBL1 CITED2 EP300 CREBBP RBL2 | lung; alveolar cells type I[>=Low] |
|   HP:0010775 | 0.00183757768757 | 0.222222222222 | EP300 CREBBP | Vascular ring |
|   HP:0011087 | 0.00183757768757 | 0.222222222222 | EP300 CREBBP | Talon cusp |
|   HP:0410266 | 0.00183757768757 | 0.222222222222 | EP300 CREBBP | Visceral hemangioma |
|   HP:0001128 | 0.00183757768757 | 0.222222222222 | EP300 CREBBP | Trichiasis |
|   HP:0031207 | 0.00183757768757 | 0.222222222222 | EP300 CREBBP | Hepatic hemangioma |
|   KEGG:04068 | 0.00184766477855 | 0.333333333333 | CREBBP EP300 RBL2 | FoxO signaling pathway |
|   REAC:R-HSA-212436 | 0.00194258475403 | 0.666666666667 | RBL2 RBL1 CITED2 EP300 CITED1 CREBBP | Generic Transcription Pathway |
|   WP:WP53 | 0.00202353509847 | 0.222222222222 | RBL2 RBL1 | ID signaling pathway |
|   REAC:R-HSA-1234174 | 0.00205183750398 | 0.333333333333 | CITED2 EP300 CREBBP | Cellular response to hypoxia |
|   REAC:R-HSA-9818028 | 0.00223242997382 | 0.222222222222 | EP300 CREBBP | NFE2L2 regulates pentose phosphate pathway genes |
|   GO:0090100 | 0.00234919252133 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
|   HP:0033777 | 0.00306165140522 | 0.222222222222 | EP300 CREBBP | Supernumerary cusp |
|   HP:0009715 | 0.00306165140522 | 0.222222222222 | EP300 CREBBP | Papillary cystadenoma of the epididymis |
|   HP:0030421 | 0.00306165140522 | 0.222222222222 | EP300 CREBBP | Epididymal neoplasm |
|   REAC:R-HSA-9617629 | 0.00358554253109 | 0.222222222222 | EP300 CREBBP | Regulation of FOXO transcriptional activity by acetylation |
|   WP:WP179 | 0.00360642845821 | 0.333333333333 | RBL1 EP300 RBL2 | Cell cycle |
|   REAC:R-HSA-73857 | 0.00367767854286 | 0.666666666667 | RBL2 RBL1 CITED2 EP300 CITED1 CREBBP | RNA Polymerase II Transcription |
|   REAC:R-HSA-8941856 | 0.00438093013445 | 0.222222222222 | EP300 CREBBP | RUNX3 regulates NOTCH signaling |
|   REAC:R-HSA-210744 | 0.00438093013445 | 0.222222222222 | EP300 CREBBP | Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells |
|   HP:0002700 | 0.00459101044859 | 0.222222222222 | EP300 CREBBP | Large foramen magnum |
|   HP:0004411 | 0.00459101044859 | 0.222222222222 | EP300 CREBBP | Deviated nasal septum |
|   HP:0100852 | 0.00459101044859 | 0.222222222222 | EP300 CREBBP | Abnormal fear-induced behavior |
|   CORUM:5614 | 0.00465362752882 | 0.222222222222 | RBL2 RBL1 | Emerin complex 32 |
|   WP:WP3657 | 0.0052310849594 | 0.222222222222 | EP300 CREBBP | Hematopoietic stem cell gene regulation by GABP alpha beta complex |
|   REAC:R-HSA-3371568 | 0.00620898744994 | 0.222222222222 | EP300 CREBBP | Attenuation phase |
|   HP:0011335 | 0.0064253619375 | 0.222222222222 | EP300 CREBBP | Frontal hirsutism |
|   HP:0030434 | 0.0064253619375 | 0.222222222222 | EP300 CREBBP | Pilomatrixoma |
|   REAC:R-HSA-918233 | 0.00724150508664 | 0.222222222222 | EP300 CREBBP | TRAF3-dependent IRF activation pathway |
|   HPA:0301371 | 0.00724785562608 | 0.666666666667 | BDH2 RBL1 CITED2 EP300 CREBBP RBL2 | lung; alveolar cells type II[>=Low] |
|   HPA:0301362 | 0.00758502645388 | 0.555555555556 | CITED2 CREBBP EP300 BDH2 RBL2 | lung; alveolar cells type I[>=Medium] |
|   REAC:R-HSA-74160 | 0.00759942737987 | 0.666666666667 | RBL2 RBL1 CITED2 EP300 CITED1 CREBBP | Gene expression (Transcription) |
|   REAC:R-HSA-3700989 | 0.00765511426945 | 0.444444444444 | CREBBP RBL1 EP300 RBL2 | Transcriptional Regulation by TP53 |
|   REAC:R-HSA-9013695 | 0.00835291407054 | 0.222222222222 | EP300 CREBBP | NOTCH4 Intracellular Domain Regulates Transcription |
|   REAC:R-HSA-1362300 | 0.00835291407054 | 0.222222222222 | RBL2 RBL1 | Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 |
|   HP:0002341 | 0.00856441317229 | 0.222222222222 | EP300 CREBBP | Cervical cord compression |
|   HP:0031251 | 0.00856441317229 | 0.222222222222 | EP300 CREBBP | Abnormal subclavian artery morphology |
|   REAC:R-HSA-1368082 | 0.00954313848115 | 0.222222222222 | EP300 CREBBP | RORA activates gene expression |
|   REAC:R-HSA-9818027 | 0.00954313848115 | 0.222222222222 | EP300 CREBBP | NFE2L2 regulating anti-oxidant/detoxification enzymes |
|   HP:0010314 | 0.0110078716337 | 0.222222222222 | EP300 CREBBP | Premature thelarche |
|   GO:1903844 | 0.0121592546484 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | regulation of cellular response to transforming growth factor beta stimulus |
|   GO:0017015 | 0.0121592546484 | 0.444444444444 | CITED2 CITED1 EP300 CREBBP | regulation of transforming growth factor beta receptor signaling pathway |
|   REAC:R-HSA-9793380 | 0.0121597301349 | 0.222222222222 | EP300 CREBBP | Formation of paraxial mesoderm |
|   REAC:R-HSA-1362277 | 0.0121597301349 | 0.222222222222 | RBL2 RBL1 | Transcription of E2F targets under negative control by DREAM complex |
|   REAC:R-HSA-9018519 | 0.0122778305747 | 0.333333333333 | CITED1 EP300 CREBBP | Estrogen-dependent gene expression |
|   WP:WP3414 | 0.012380386891 | 0.222222222222 | EP300 CREBBP | Initiation of transcription and translation elongation at the HIV 1 LTR |
|   HP:0009714 | 0.0137554449829 | 0.222222222222 | EP300 CREBBP | Abnormal epididymis morphology |
|   HP:0007086 | 0.0137554449829 | 0.222222222222 | EP300 CREBBP | Social and occupational deterioration |
|   HP:0002697 | 0.0137554449829 | 0.222222222222 | EP300 CREBBP | Parietal foramina |
|   REAC:R-HSA-5621575 | 0.0150906736209 | 0.222222222222 | EP300 CREBBP | CD209 (DC-SIGN) signaling |
|   REAC:R-HSA-9013508 | 0.0150906736209 | 0.222222222222 | EP300 CREBBP | NOTCH3 Intracellular Domain Regulates Transcription |
|   WP:WP4241 | 0.0151103173393 | 0.222222222222 | EP300 CREBBP | Type 2 papillary renal cell carcinoma |
|   GO:0043627 | 0.0162365457737 | 0.333333333333 | CITED2 EP300 CITED1 | response to estrogen |
|   HP:0000273 | 0.0168068410612 | 0.222222222222 | EP300 CREBBP | Facial grimacing |
|   HP:0000321 | 0.0168068410612 | 0.222222222222 | EP300 CREBBP | Square face |
|   HP:0010562 | 0.0168068410612 | 0.222222222222 | EP300 CREBBP | Keloids |
|   KEGG:04330 | 0.0189437044705 | 0.222222222222 | EP300 CREBBP | Notch signaling pathway |
|   REAC:R-HSA-3371571 | 0.0200751738188 | 0.222222222222 | EP300 CREBBP | HSF1-dependent transactivation |
|   HP:0010066 | 0.0201617678902 | 0.222222222222 | EP300 CREBBP | Duplication of phalanx of hallux |
|   HP:0010181 | 0.0201617678902 | 0.222222222222 | EP300 CREBBP | Duplication of phalanx of toe |
|   HP:0012304 | 0.0201617678902 | 0.222222222222 | EP300 CREBBP | Hypoplastic aortic arch |
|   REAC:R-HSA-186712 | 0.0237893486791 | 0.222222222222 | EP300 CREBBP | Regulation of beta-cell development |
|   KEGG:04720 | 0.0239862693019 | 0.222222222222 | EP300 CREBBP | Long-term potentiation |
|   REAC:R-HSA-1538133 | 0.0257635620293 | 0.222222222222 | RBL2 RBL1 | G0 and Early G1 |
|   KEGG:03250 | 0.0267263448961 | 0.222222222222 | EP300 CREBBP | Viral life cycle - HIV-1 |
|   WP:WP560 | 0.0274127875531 | 0.222222222222 | EP300 CREBBP | TGF beta receptor signaling |
|   HP:0009937 | 0.0277810467869 | 0.222222222222 | EP300 CREBBP | Facial hirsutism |
|   REAC:R-HSA-69205 | 0.0278157587689 | 0.222222222222 | RBL2 RBL1 | G1/S-Specific Transcription |
|   WP:WP4816 | 0.0300346853536 | 0.222222222222 | EP300 CREBBP | TGF beta receptor signaling in skeletal dysplasias |
|   HP:0012842 | 0.0320448157979 | 0.222222222222 | EP300 CREBBP | Skin appendage neoplasm |
|   REAC:R-HSA-933541 | 0.032153801025 | 0.222222222222 | EP300 CREBBP | TRAF6 mediated IRF7 activation |
|   KEGG:05211 | 0.0347423807791 | 0.222222222222 | EP300 CREBBP | Renal cell carcinoma |
|   HP:0000559 | 0.0366109494459 | 0.222222222222 | EP300 CREBBP | Corneal scarring |
|   HP:0001869 | 0.0366109494459 | 0.222222222222 | EP300 CREBBP | Deep plantar creases |
|   HP:0002699 | 0.0366109494459 | 0.222222222222 | EP300 CREBBP | Abnormal foramen magnum morphology |
|   HPA:0301372 | 0.0372867131818 | 0.555555555556 | CITED2 CREBBP EP300 BDH2 RBL2 | lung; alveolar cells type II[>=Medium] |
|   REAC:R-HSA-8939211 | 0.0375559727424 | 0.333333333333 | CITED1 EP300 CREBBP | ESR-mediated signaling |
|   HP:0002869 | 0.0414791566521 | 0.222222222222 | EP300 CREBBP | Flared iliac wing |
|   HP:0006349 | 0.0414791566521 | 0.222222222222 | EP300 CREBBP | Agenesis of permanent teeth |
|   HP:0009889 | 0.0414791566521 | 0.222222222222 | EP300 CREBBP | Localized hirsutism |
|   HP:0000387 | 0.0414791566521 | 0.222222222222 | EP300 CREBBP | Absent earlobe |
|   WP:WP5180 | 0.0432890882108 | 0.222222222222 | RBL2 RBL1 | DYRK1A involvement regarding cell proliferation in brain development |
|   HP:0010059 | 0.0466491465176 | 0.222222222222 | EP300 CREBBP | Broad hallux phalanx |
|   HP:0031546 | 0.0482177591518 | 0.333333333333 | CITED2 EP300 CREBBP | Cardiac conduction abnormality |
|   REAC:R-HSA-2173796 | 0.0497823629923 | 0.222222222222 | EP300 RBL1 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
|   WP:WP3651 | 0.0499409119424 | 0.222222222222 | EP300 CREBBP | Pathways affected in adenoid cystic carcinoma |
|   CORUM:5198 | 0.0499842271994 | 0.111111111111 | CREBBP | CBP-RARA-RXRA-DNA complex, ligand stimulated |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
|---|---|---|---|---|---|
|  BDH2 |  CITED1 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  EP300 |  CITED1 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  CREBBP |  CITED1 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  EP300 |  CREBBP | 0.999 | 0.476           |          | bioplex_WMM     bioplex3_WMM     boldt     youn_WMM     fraction     boldt_WMM     |
|  RBL2 |  RBL1 | 0.996 | 0.118           |          | bioplex_WMM     bioplex3_WMM     WMM_only     boldt_WMM     |
|  MATCAP1 |  CITED1 | 0.987 |            |          | bioplex3_HEK293     bioplex3_WMM     WMM_only     |
|  RBL2 |  CITED1 | 0.975 |            |          | bioplex3_HEK293     bioplex3_WMM     WMM_only     |
|  RBL1 |  CITED1 | 0.94 |            |          | bioplex3_HEK293     bioplex3_WMM     WMM_only     |
|  CREBBP |  C3orf62 | 0.908 |            |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
|  CREBBP |  BDH2 | 0.905 | 0.024           |          | bioplex3_WMM     WMM_only     |
|  EP300 |  RBL1 | 0.877 | 0.323130434783           |          | bioplex_WMM     bioplex3_WMM     boldt     boldt_WMM     WMM_only     |
|  RBL2 |  CREBBP | 0.846 | 0.362           |          | bioplex_WMM     bioplex3_WMM     WMM_only     boldt_WMM     |
|  EP300 |  BDH2 | 0.84 | 0.056           |          | bioplex3_WMM     WMM_only     |
|  EP300 |  C3orf62 | 0.831 |            |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
|  EP300 |  CITED2 | 0.83 |            |          | hein_WMM     hein ()     |
|  RBL1 |  CREBBP | 0.828 | 0.307536384977           |          | bioplex_WMM     bioplex3_WMM     boldt     boldt_WMM     WMM_only     |
|  EP300 |  RBL2 | 0.482 | 0.226           |          | bioplex_WMM     bioplex3_WMM     WMM_only     boldt_WMM     |
|  CREBBP |  MATCAP1 | 0.415 |            |          | bioplex3_WMM     WMM_only     |
|  MATCAP1 |  BDH2 | 0.415 |            |          | bioplex3_WMM     WMM_only     |
|  RBL1 |  MATCAP1 | 0.278 |            |          | bioplex3_WMM     WMM_only     |
|  EP300 |  MATCAP1 | 0.254 |            |          | bioplex3_WMM     WMM_only     |
|  RBL2 |  MATCAP1 | 0.25 |            |          | bioplex3_WMM     WMM_only     |
|  RBL1 |  C3orf62 | 0.104 |            |          | bioplex ()     bioplex_WMM     |
|  RBL1 |  BDH2 | 0.093 | 0.014           |          | bioplex3_WMM     WMM_only     |
|  RBL2 |  BDH2 | 0.078 | 0.036           |          | bioplex3_WMM     WMM_only     |
Related Complexes